English | Español

Astrazeneca Pharmaceuticals Lp
Mark Iandolo | Nov 22, 2017

AstraZeneca's benralizumab receives positive opinion from European Medicines Agency's CHMP
Mark Iandolo | Nov 22, 2017

AstraZeneca, MedImmune deliver 28 presentations at AHA Scientific Sessions
Nicholas Gueguen | Aug 1, 2017

MedImmune, Sanofi Pasteur to create and market respiratory tract illness prevention drug
Nicholas Gueguen | Jul 23, 2017

FDA approves AstraZeneca's Tagrisso for treating certain forms of lung cancer
Robert Hadley | Jul 5, 2017

AstraZeneca’s Faslodex to treat breast cancer a step closer to approval in Europe
Erianne Leatherman | Jun 29, 2017

AstraZeneca’s Imfinzi gains FDA accelerated approval for bladder cancer patients
Ruth de Jauregui | Jun 7, 2017

AstraZeneca sees positive results in treating BRCA-mutated breast cancer patients with Lynparza
Robert Hadley | Jun 4, 2017

AstraZeneca to reveal results of three cancer-fighting drugs at ASCO meeting

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+ Pharmaceuticals
Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program
+ Pharmaceuticals
Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’